We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Intellectual Property Office offers different methods of accelerating the processing of your patent application.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
How the government monitors imports into the UK.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
The CDRN laboratory provides timely access to Clostridioides difficile culture, ribotyping and DNA fingerprinting services, according to standardised submission criteria.
As part of Dstl's commitment to improving access to technologies, we're making some of our intellectual property (IP) available for free.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
How responders can reduce the risk of communications disruption during emergencies by using ResilienceDirect, HITS and Telecoms Sub-Groups.
Information about the EU Regulations and their implementation in Northern Ireland
This ground-breaking programme of research by the IPO looks at the various strategic drivers for intellectual property and the impact this has on IP demand.
Information for British nationals affected by rape or sexual assault abroad, including how to access medical treatment and legal advice in the UK.
Information on the diagnosis, prevention and treatment of human parainfluenza viruses (HPIVs).
Guidance on the ventilation of indoor spaces to reduce the spread of respiratory infections, including coronavirus (COVID-19).
An overview of risks to pregnant women from infections: current screening, vaccination, treatment and prevention programmes.
Diagnostic and advisory services for Lyme disease.
Data on the real-world efficacy of the COVID-19 vaccines.
This service allows hospitals to record incidents of infection after surgery, track patient results and review or change practice to avoid further infections.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.